المؤلفون: O. V. Yakushevskaya, О. В. Якушевская

المصدر: Meditsinskiy sovet = Medical Council; № 4 (2024); 141-146 ; Медицинский Совет; № 4 (2024); 141-146 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: преждевременная недостаточность яичников, menopausal syndrome, 17β-estradiol, levonorgestrel, abnormal uterine bleeding, premature ovarian failure, климактерический синдром, 17β-эстрадиол, левоноргестрел, аномальное маточное кровотечение

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/8201/7235Test; The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767–794. https://doi.org/10.1097/GME.0000000000002028Test.; Tanbo TG, Fedorcsak PZ. Can time to menopause be predicted? Acta Obstet Gynecol Scand. 2021;100(11):1961–1968. https://doi.org/10.1111/aogs.14253Test.; Юренева СВ, Якушевская ОВ, Комедина ВИ. Перименопауза – золотое время для профилактики заболеваний, ассоциированных с возрастом. Эффективная фармакотерапия. 2021;17(13):36–44. Режим доступа: https://umedp.ru/articles/perimenopauza_zolotoe_vremya_dlya_profilaktiki_zabolevaniy_assotsiirovannykh_s_vozrastom.htmlTest.; Turner RJ, Kerber IJ. Eu-estrogenemia, WHI, timing and the “geripause”. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1461–1463. https://doi.org/10.1007/s00192-008-0708-6Test.; Юренева СВ, Дубровина АВ. Эволюция целей менопаузальной гормональной терапии. От лечения приливов к новым горизонтам кардиометаболической протекции. Акушерство и гинекология. 2018;(6):18–24. https://doi.org/10.18565/aig.2018.6.18-24Test.; Сметник ВП. Медицина климактерия. М.: Литера; 2009. 124 с.; Wiegratz I, Kuhl H. Progestogen therapies: differences in clinical effects? Trends Endocrinol Metab. 2004;15(6):277–285. https://doi.org/10.1016/j.tem.2004.06.006Test.; Raymond EG, Coeytaux F, Gemzell-Danielsson K, Moore K, Trussell J, Winikoff B. Embracing post-fertilisation methods of family planning: a call to action. J Fam Plann Reprod Health Care. 2013;39(4):244–246. https://doi.org/10.1136/jfprhc-2013-100702Test.; Friend DR. Development of controlled release systems over the past 50 years in the area of contraception. J Control Release. 2016;240:235–241. https://doi.org/10.1016/j.jconrel.2015.12.043Test.; Kubíková D. Menopauzální symptomy a hormonální substituční terapie. Praktické lékárenství. 2014;10(2). Available at: https://www.solen.sk/sk/casopisy/prakticke-lekarnictvo/menopauzalni-symptomy-a-hormonalnisubstitucni-terapieTest.; Basaraba CN, Westhoff CL, Pike MC, Nandakumar R, Cremers S. Estimating systemic exposure to levonorgestrel from an oral contraceptive. Contraception. 2017;95(4):398–404. https://doi.org/10.1016/j.contraception.2016.12.007Test.; Reinecke I, Hofmann B, Mesic E, Drenth HJ, Garmann D. An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes. J Clin Pharmacol. 2018;58(12):1639–1654. https://doi.org/10.1002/jcph.1288Test.; Fotherby K. Levonorgestrel. Clinical pharmacokinetics. Clin Pharmacokinet. 1995;28(3):203–215 https://doi.org/10.2165/00003088-199528030-00003Test.; Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2003;(Suppl. 1):S7-S16. https://doi.org/10.1016/j.maturitas.2003.09.014Test.; Knörr K, Knörr-Gärtner H, Beller FK, Lauritzen C. Geburtshilfe und Gynäkologie: Physiologie und Pathologie der Reproduktion. Springer-Verlag; 1989. Available at: https://link.springer.com/book/10.1007/978-3-642-95583-9Test.; Jetley S, Rana S, Jairajpuri ZS. Morphological spectrum of endometrial pathology in middle-aged women with atypical uterine bleeding: a study of 219 cases. J Midlife Health. 2013;4(4):216–220. https://doi.org/10.4103/0976-7800.122242Test.; Кузнецова ИВ., Тихоновская ИВ. Менопаузальная гормональная терапия у женщин в перименопаузе с аномальными маточными кровотечениями. Доктор.Ру. 2016;120(3):25–29. Режим доступа: https://journaldoctor.ru/catalog/endokrinologiya/menopauzalnayagormonalnaya-terapiya-u-zhenshchin-v-perimenopauze-s-anomalnymimatochnymi-krovoteche/?lang=ruTest.; Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM et al. 17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology. 2012;153(11):5467–5479. https://doi.org/10.1210/en.2012-1464Test.; Walker DM, Gore AC. Epigenetic impacts of endocrine disruptors in the brain. Front Neuroendocrinol. 2017;44:1–26. https://doi.org/10.1016/j.yfrne.2016.09.002Test.; Jayaraman A, Pike CJ. Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons. Mol Cell Endocrinol. 2014;384(1-2):52–60. https://doi.org/10.1016/j.mce.2014.01.003Test.; Darney PD. The androgenicity of progestins. Am J Med. 1995;98(1A):104S–110S. https://doi.org/10.1016/s0002-9343Test(99)80067-9.; Davis SR, Wahlin-Jacobsen S. Testosterone in women – the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980–992. https://doi.org/10.1016/S2213-8587Test(15)00284-3.; Lello S, Cavani A. Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology. Int J Endocrinol. 2014;2014:102184. https://doi.org/10.1155/2014/102184Test.; Skouby SO. Menopause weight gain: the influence of TSEC intervention. Menopause. 2016;23(4):357–358. https://doi.org/10.1097/GME.0000000000000623Test.; Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2015;350:h2135. https://doi.org/10.1136/bmj.h2135Test.; Terauchi M, Honjo H, Mizunuma H, Aso T. Effects of oral estradiol and levonorgestrel on cardiovascular risk markers in postmenopausal women. Arch Gynecol Obstet. 2012;285(6):1647–1656. https://doi.org/10.1007/s00404-012-2222-9Test.; Сметник ВП, Сухих ГТ, Андреева ЕН, Балан ВЕ, Гависова АА, Григорян ОР и др. Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста: клинические рекомендации. М.; 2015.; Аполихина ИА, Тарнаева ЛА, Кондратьева НЕ. Результаты исследований биоэквивалентности препаратов диеногеста, прогестерона, левоноргестрела + эстрадиол у здоровых добровольцев после однократного приема натощак. Акушерство и гинекология. 2023;(1):110–121. https://doi.org/10.18565/aig.2022.304Test.; https://www.med-sovet.pro/jour/article/view/8201Test

الإتاحة: https://doi.org/10.21518/ms2024-080Test
https://doi.org/10.1097/GME.0000000000002028Test
https://doi.org/10.1007/s00192-008-0708-6Test
https://doi.org/10.18565/aig.2018.6.18-24Test
https://doi.org/10.1136/jfprhc-2013-100702Test
https://doi.org/10.1016/j.jconrel.2015.12.043Test
https://doi.org/10.1016/j.contraception.2016.12.007Test
https://doi.org/10.1002/jcph.1288Test
https://doi.org/10.2165/00003088-199528030-00003Test
https://doi.org/10.1016/j.maturitas.2003.09.014Test

المؤلفون: Leila V. Adamyan, Elena V. Sibirskaya, Irina V. Karachentsova, Laura G. Pivazyan, Maria A. Loshkareva, Yuliya A. Kirillova, Sabina K. Murvatova, Kamila K. Murvatova, Л. В. Адамян, Е. В. Сибирская, И. В. Караченцова, Л. Г. Пивазян, М. А. Лошкарева, Ю. А. Кириллова, С. К. Мурватова, К. К. Мурватова

المساهمون: Not specified., Отсутствует.

المصدر: Current Pediatrics; Том 22, № 4 (2023); 319-323 ; Вопросы современной педиатрии; Том 22, № 4 (2023); 319-323 ; 1682-5535 ; 1682-5527

مصطلحات موضوعية: железодефицитная анемия, clinical case, abnormal uterine bleeding in adolescence, iron deficiency anemia, клинический случай, аномальное маточное кровотечение пубертатного периода

وصف الملف: application/pdf

العلاقة: https://vsp.spr-journal.ru/jour/article/view/3269/1314Test; Адамян Л.В., Сибирская Е.В., Колтунов И.Е. и др. Аномальные маточные кровотечения пубертатного периода: диагностика и тактика лечения (обзор литературы) // Проблемы репродукции. — 2016. — Т. 22. — № 6. — С. 89–97. — doi: https://doi.org/10.17116/repro201622689-97Test; Deligeoroglou E, Karountzos V, Creatsas G. Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology. Gynecol Endocrinol. 2013;29(1):74–78. doi: https://doi.org/10.3109/09513590.2012.705384Test; Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017;40:3–22. doi: https://doi.org/10.1016/j.bpobgyn.2016.09.011Test; Клинические рекомендации (проект). Аномальные маточные кровотечения в пубертатном периоде // Репродуктивное здоровье детей и подростков. — 2021. — Т. 17. — № 3. — С. 5–30. — doi: https://doi.org/10.33029/1816-2134-2021-17-3-5-30Test; Сибирская Е.В., Адамян Л.В., Логинова О.Н. и др. Аномальные маточные кровотечения пубертатного периода: определение и тактика ведения (обзор литературы) // Проблемы репродукции. — 2015. — Т. 21. — № 5. — С. 74–79. — doi: https://doi.org/10.17116/repro201521574-79Test; Доброхотова Ю.Э., Каранашева А.Х. Аномальные маточные кровотечения репродуктивного и пременопаузального периода: современные алгоритмы обследования и лечения // Актуальные вопросы женского здоровья. — 2022. — № 1. — С. 8–12. — doi: https://doi.org/10.46393/2713122TestХ_2022_1_8; Lebduska E, Beshear D, Spataro BM. Abnormal Uterine Bleeding. Med Clin North Am. 2023;107(2):235–246. doi: https://doi.org/10.1016/j.mcna.2022.10.014Test; Мишина А.И., Казакова А.В., Уварова Е.В. Факторы риска аномальных маточных кровотечений у девочек пубертатного периода, прогнозирование и профилактика // Репродуктивное здоровье детей и подростков. — 2022. — Т. 18. — № 1. — С. 47–55. — doi: https://www.doi.org/10.33029/1816-2134-2021-17-4-47-55Test; Детская гинекология: справочник / сост. Б.Б. Маркин, Э.Ю. Яковлева. — Киев: Знання; 2004. — С. 173–177. — (Библиотека практикующего врача).; Дикке Г.Б. Терапевтическая тактика при аномальных маточных кровотечениях, не связанных со структурными аномалиями матки // Медицинский Совет. — 2018. — № 21. — С. 168–172. — doi: https://doi.org/10.21518/2079-701X-2018-21-168-172Test; Сибирская Е.В., Пивазян Л.Г. Гормональная терапия аномальных маточных кровотечений у женщин позднего репродуктивного возраста. Вопросы гинекологии, акушерства и перинатологии. — 2020. — Т. 19. — № 2. — С. 129–135. — doi: https://doi.org/10.20953/1726-1678-2020-2-129-135Test; Mirza FG, Abdul-Kadir R, Breymann C, et al. Impact and management of iron deficiency and iron deficiency anemia in women’s health. Expert Rev Hematol. 2018;11(9):727–736. doi: https://doi.org/10.1080/17474086.2018.1502081Test; Селихова М.С., Зверева Е.С. Аномальные маточные кровотечения у девочек. Что делать? // РМЖ. Мать и дитя. — 2019. — Т. 2. — № 4. — С. 351–354. — doi: https://doi.org/10.32364/2618-8430-2019-2-4-351-354Test; Achanna KS, Nanda J. Evaluation and management of abnormal uterine bleeding. Med J Malaysia. 2022;77(3):374–383.; DeLoughery TG. Iron Deficiency Anemia. Med Clin North Am. 2017; 101(2):319–332. doi: https://doi.org/10.1016/j.mcna.2016.09.004Test; Васильева Е.В., Асланян К.С., Пискунова С.Г. Железодефицитная анемия у детей: современный взгляд гематолога // Главврач Юга России. — 2017. — № 3. — С. 6–10.; Богданов А.Н., Мазуров В.И. Железодефицитные анемии в XXI веке // Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. — 2016. — Т. 8. — № 4. — С. 106–112.; Жорова В.Е., Хилькевич Е.Г. Частота и распространенность железодефицитной анемии // Медицинский Совет. — 2018. — № 13. — С. 78–81. — doi: https://doi.org/10.21518/2079-701X-2018-13-78-81Test; Баранов И.И., Сальникова И.А., Нестерова Л.А. Клинические рекомендации по диагностике и лечению железодефицитных состояний: взгляд из 2022 г. // Акушерство и гинекология: Новости. Мнения. Обучение. — 2022. — Т. 10. — № 2. — С. 56–64. — doi: https://doi.org/10.33029/2303-9698-2022-10-2-56-64Test; Camaschella C. Iron defi ciency. Blood. 2019;133:30–39. doi: https://doi.org/10.1182/blood2018-05-815944Test; Доброхотова Ю.Э., Хлынова С.А. Коррекция железодефицитной анемии у гинекологических больных // Лечебное дело. — 2017. — № 3. — С. 31–36. [Dobrokhotova YuE, Khlynova SA. Correction of Iron Deficiency Anemia in Gynecological Patients. Lechebnoe delo. 2017;(3):31–36. (In Russ).]; Уварова Е.В. Аномальные маточные кровотечения пубертатного периода // Репродуктивное здоровье детей и подростков. — 2018. — № 1. — С. 64–91.; Чернуха Г.Е., Ильина Л.М., Иванов И.А. Аномальные маточные кровотечения: ставим диагноз и выбираем лечение // Гинекология. — 2018. — Т. 20. — № 4. — С. 4–8. — doi: https://doi.org/10.26442/2079-5696_2018.4.4-8Test; Elmaoğulları S, Aycan Z. Abnormal Uterine Bleeding in Adolescents. J Clin Res Pediatr Endocrinol. 2018;10(3):191–197. doi: https://doi.org/10.4274/jcrpe.0014Test; Ramalho I, Leite H, Águas F. Abnormal Uterine Bleeding in Adolescents: A Multidisciplinary Approach. Acta Med Port. 2021; 34(4):291–297. doi: https://doi.org/10.20344/amp.12829Test; Wang Y, Zhao L, Feng X. Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency. Front Med (Lausanne). 2020;7:181. doi: https://doi.org/10.3389/fmed.2020.00181Test; Kanbur NO, Derman O, Aksu T. Menorrhagia at menarche: a case report. Int J Adolesc Med Health. 2003;15(2):161–164. doi: https://doi.org/10.1515/ijamh.2003.15.2.161Test; Cooke AG, McCavit TL, Buchanan GR. Iron Deficiency Anemia in Adolescents Who Present with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2017;30(2):247–250. doi: https://doi.org/10.1016/j.jpag.2016.10.010Test; Сибирская Е.В., Адамян Л.В., Яцык С.П. и др. Аномальное маточное кровотечение пубертатного периода — состояние гормонального фона // Вопросы современной педиатрии. — 2014. — Т. 13. — № 4. — С. 136–139. — doi: https://doi.org/10.15690/vsp.v13i4.1098Test; Адамян Л.В., Петряйкина Е.Е., Сибирская Е.В. и др. Аномальные маточные кровотечения пубертатного периода у девочек-подростков: ведение, диагностика и лечение // Проблемы репродукции. — 2019. — Т. 25. — № 3. — С. 99–103. — doi: https://doi.org/10.17116/repro20192503199Test; Benson CS, Shah A, Stanworth SJ. The effect of iron deficiency and anaemia on women’s health. Anaesthesia. 2021;76 Suppl 4: 84–95. doi: https://doi.org/10.1111/anae.15405Test; https://vsp.spr-journal.ru/jour/article/view/3269Test

الإتاحة: https://doi.org/10.15690/vsp.v22i4.2612Test
https://doi.org/10.17116/repro201622689-97Test
https://doi.org/10.3109/09513590.2012.705384Test
https://doi.org/10.1016/j.bpobgyn.2016.09.011Test
https://doi.org/10.33029/1816-2134-2021-17-3-5-30Test
https://doi.org/10.17116/repro201521574-79Test
https://doi.org/10.46393/2713122TestХ_2022_1_8
https://doi.org/10.1016/j.mcna.2022.10.014Test
https://doi.org/10.33029/1816-2134-2021-17-4-47-55Test
https://doi.org/10.21518/2079-701X-2018-21-168-172Test

المؤلفون: Yu. S. Artemenko, M. B. Khamoshina, V. A. Ryabova, Z. V. Zyukina, Ю. С. Артеменко, М. Б. Хамошина, В. А. Рябова, З. В. Зюкина

المصدر: Meditsinskiy sovet = Medical Council; № 5 (2022); 32-39 ; Медицинский Совет; № 5 (2022); 32-39 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: молекулярно-генетические маркеры, reproductive health, adipokines, sexual development, female infertility, endometriosis, abnormal uterine bleeding, chronic inflammation, molecular genetic markers, половое развитие, бесплодие, эндометриоз, аномальное маточное кровотечение, хроническое воспаление

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/6788/6121Test; Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104–112. https://doi.org/10.14341Test/ DM2004116-17.; Kelly T., Yang W., Chen C.S., Reynolds K., He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431–1437. https://doi.org/10.1038/ijo.2008.102Test.; Wang Y.C., McPherson K., Marsh T., Gortmaker S.L., Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–825. https://doi.org/10.1016/S0140-6736Test(11)60814-3.; Schetz M., De Jong A., Deane A.M., Druml W., Hemelaar P., Pelosi. P. et al. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019;45(6):757–769. https://doi.org/10.1007/s00134-019-05594-1Test.; Broughton D.E., Moley K.H. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107(4):840–847. https://doi.org/10.1016/j.fertnstert.2017.01.017Test.; Willemsen R.H., Dunger D.B. Normal Variation in Pubertal Timing: Genetic Determinants in Relation to Growth and Adiposity. Endocr Dev. 2016;29:17–35. https://doi.org/10.1159/000438957Test.; Biro F.M., Kiess W. Contemporary Trends in Onset and Completion of Puberty, Gain in Height and Adiposity. Endocr Dev. 2016;29:122–133. https://doi.org/10.1159/000438881Test.; Левкович М.А., Андреева В.О., Хошаби К.Э. Роль толл-подобных рецепторов и полиморфизма их генов в патогенезе овариальной дисфункции у девочек-подростков с ожирением. Репродуктивное здоровье детей и подростков. 2020;16(3):64–72. https://doi.org/10.33029/1816-2134-2020-16-3-64-72Test.; Zhang Y., Hu M., Ma H., Qu J., Wang Y., Hou L. et al. The impairment of reproduction in db/db mice is not mediated by intraovarian defective leptin signaling. Fertil Steril. 2012;97(5):1183–1191. https://doi.org/10.1016/j.fertnstert.2012.01.126Test.; Kawwass J.F., Summer R., Kallen C.B. Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review. Mol Hum Reprod. 2015;21(8):617–632. https://doi.org/10.1093/molehr/gav025Test.; He Y., Lu Y., Zhu Q., Wang Y., Lindheim S. R., Qi J. et al. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. Am J Obstet Gynecol. 2019;221(2):138.e1–138.e12. https://doi.org/10.1016/j.ajog.2019.03.011Test.; Xu L., Shi Y., Gu J., Wang Y., Wang L., You L. et al. Association between ghrelin gene variations, body mass index, and waist-to-hip ratio in patients with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2014;122(3):144–148. https://doi.org/10.1055/s-0034-1367024Test.; Day F.R., Hinds D.A., Tung J.Y., Stolk L., Styrkarsdottir U., Saxena R. et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464. https://doi.org/10.1038/ncomms9464Test.; Batarfi A.A., Filimban N., Bajouh O. S., Dallol A., Chaudhary A.G., Bakhashab S. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia. BMC Med Genet. 2019;20(1):144. https://doi.org/10.1186/s12881-019-0876-xTest.; Silvestris E., de Pergola G., Rosania R., Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22. https://doi.org/10.1186/s12958-018-0336-zTest.; Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97. https://doi.org/10.1038/nri2921Test.; Nieuwenhuis D., Pujol-Gualdo N., Arnoldussen I.A.C., Kiliaan A.J. Adipokines: A gear shift in puberty. Obes Rev. 2020;21(6):e13005. https://doi.org/10.1111/obr.13005Test.; Zhao S., Kusminski C.M., Elmquist J.K., Scherer P.E. Leptin: Less Is More. Diabetes. 2020;69(5):823–829. https://doi.org/10.2337/dbi19-0018Test.; Pan W.W., Myers M.G. Jr. Leptin and the maintenance of elevated body weight. Nat Rev Neurosci. 2018;19(2):95–105. https://doi.org/10.1038/nrn.2017.168Test.; Caron A., Lee S., Elmquist J.K., Gautron L. Leptin and brain-adipose crosstalks. Nat Rev Neurosci. 2018;19(3):153–165. https://doi.org/10.1038/nrn.2018.7Test.; Çetinkaya S., Güran T., Kurnaz E., Keskin M., Sağsak E., Savaş Erdeve S. et al. A Patient with Proopiomelanocortin Deficiency: An Increasingly Important Diagnosis to Make. J Clin Res Pediatr Endocrinol. 2018;10(1):68–73. https://doi.org/10.4274/jcrpe.4638Test.; Baldini G., Phelan K.D. The melanocortin pathway and control of appetiteprogress and therapeutic implications. J Endocrinol. 2019;241(1):R1–R33. https://doi.org/10.1530/JOE-18-0596Test.; Baver S.B., Hope K., Guyot S., Bjørbaek C., Kaczorowski C., O’Connell K.M. Leptin modulates the intrinsic excitability of AgRP/NPY neurons in the arcuate nucleus of the hypothalamus. J Neurosci. 2014;34(16):5486–5496. https://doi.org/10.1523/JNEUROSCI.4861-12.2014Test.; Michalakis K., Mintziori G., Kaprara A., Tarlatzis B.C., Goulis D.G. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism. 2013;62(4):457–478. https://doi.org/10.1016/j.metabol.2012.08.012Test.; Reinehr T., Roth C.L. Is there a causal relationship between obesity and puberty? Lancet Child Adolesc Health. 2019;3(1):44–54. https://doi.org/10.1016/S2352-4642Test(18)30306-7.; Dobrzyn K., Smolinska N., Kiezun M., Szeszko K., Rytelewska E., Kisielewska K. et al. Adiponectin: A new regulator of female reproductive system. Int J Endocrinol. 2018;7965071. https://doi.org/10.1155/2018/7965071Test.; Mathew H., Castracane V.D., Mantzoros C. Adipose tissue and reproductive health. Metabolism. 2018;86:18–32. https://doi.org/10.1016/j.metabol.2017.11.006Test.; Khan M., Joseph F. Adipose tissue and adipokines: the association with and application of adipokines in obesity. Scientifica (Cairo). 2014;328592. https://doi.org/10.1155/2014/328592Test.; Huang-Doran I., Franks S. Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2016;7:53. https://doi.org/10.3389/fendo.2016.00053Test.; Luzzo K.M., Wang Q., Purcell S.H., Chi M., Jimenez P.T., Grindler N. et al. High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation/brain defects. PLoS ONE. 2012;7(11):e49217. https://doi.org/10.1371/journal.pone.0049217Test.; Singh A., Choubey M., Bora P., Krishna A. Adiponectin and Chemerin: Contrary Adipokines in Regulating Reproduction and Metabolic Disorders. Reprod Sci. 2018;25(10):1462–1473. https://doi.org/10.1177/1933719118770547Test.; Tsatsanis C., Dermitzaki E., Avgoustinaki P., Malliaraki N., Mytaras V., Margioris A.N. The impact of adipose tissue‐derived factors on the hypothalamic‐pituitary‐gonadal (HPG) axis. Hormones (Athens). 2015;14:549–562. https://doi.org/10.14310/horm.2002.1649Test.; Souter I., Baltagi L.M., Kuleta D., Meeker J.D., Petrozza J.C. Women, weight, and fertility: the effect of body mass index on the outcome of superovulation/intrauterine insemination cycles. Fertil Steril. 2011;95(3):1042–1047. https://doi.org/10.1016/j.fertnstert.2010.11.062Test.; Provost M.P., Acharya K.S., Acharya C.R., Yeh J.S., Steward R.G., Eaton J.L. et al. Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008– 2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertil Steril. 2016;105(2):364–368. https://doi.org/10.1016/j.fertnstert.2015.10.015Test.; Luke B., Brown M.B., Stern J.E., Missmer S.A., Fujimoto V.Y., Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011;26(1):245–252. https://doi.org/10.1093/humrep/deq306Test.; Jungheim E.S., Schon S.B., Schulte M.B., DeUgarte D.A., Fowler S.A., Tuuli M.G. IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis. Hum Reprod. 2013;28(10):2720–2727. https://doi.org/10.1093/humrep/det292Test.; Rubio C., Vassena R., García D., Vernaeve V., Madero J.I. Influence of donor, recipient, and male partner body mass index on pregnancy rates in oocyte donation cycles. JBRA Assist Reprod. 2015;19(2):53–58. https://doi.org/10.5935/1518-0557.20150013Test.; Cardozo E.R., Karmon A.E., Gold J., Petrozza J.C., Styer A.K. Reproductive outcomes in oocyte donation cycles are associated with donor BMI. Hum Reprod. 2016;31(2):385–392. https://doi.org/10.1093/humrep/dev298Test.; Rhee J.S., Saben J.L., Mayer A.L., Schulte M.B., Asghar Z., Stephens C. Dietinduced obesity impairs endometrial stromal cell decidualization: a potential role for impaired autophagy. Hum Reprod. 2016;31(6):1315–1326. https://doi.org/10.1093/humrep/dew048Test.; Carpinello O.J., Sundheimer L.W., Alford C.E., Taylor R.N., DeCherney A.H. Endometriosis. In: Feingold K.R., Anawalt B., Boyce A. (eds.). Endotext. South Dartmouth (MA): MDText.com, Inc.; 2017. Available at: https://www.ncbi.nlm.nih.gov/books/NBK278996Test/.; Holdsworth-Carson S.J., Rogers P.A. The complex relationship between body mass index and endometriosis. J Endometr Pelvic Pain Disord. 2018;10(4):187–189. https://doi.org/10.1177/2284026518810586Test.; Holdsworth-Carson S.J., Dior U.P., Colgrave E.M., Healey M., Montgomery G.W., Rogers P.A., Girling J.E. The association of body mass index with endometriosis and disease severity in women with pain. J Endometr Pelvic Pain Disord. 2018;10(2):79–87. https://doi.org/10.1177/2284026518773939Test.; Yun K.Y., Hwang S.Y., Lee H.J., Kim S.C., Joo J.K., Suh D.S. et al. The association of body mass index with incidence, stage and recurrence of endometriosis: case-control study in Korean women. Clin Exp Obstet Gynecol. 2020;47(1):53–56. https://doi.org/10.31083/j.ceog.2020.01.4996Test.; Vaghar M.I. Evaluation of lifestyle and endometriosis in infertile women referring to the selected hospital of Tehran University Medical Sciences. J Family Med Prim Care. 2019;8(11):3574–3577. https://doi.org/10.4103/jfmpc.jfmpc_496_19Test; Cardoso J.V., Abrão M.S., Berardo P.T., Ferrari R., Nasciutti L.E., Machado D.E., Perini J.A. Role of cytochrome P450 2C19 polymorphisms and body mass index in endometriosis: A case-control study. Eur J Obstet Gynecol Reprod Biol. 2017;219:119–123. https://doi.org/10.1016/j.ejogrb.2017.10.027Test.; Holdsworth-Carson S.J., Chung J., Sloggett C., Mortlock S., Fung J.N., Montgomery G.W., Dior U.P. et al. Obesity does not alter endometrial gene expression in women with endometriosis. Reprod Biomed Online. 2020;41(1):113–118. https://doi.org/10.1016/j.rbmo.2020.03.015Test.; Pantelis A., Machairiotis N., Lapatsanis D.P. The Formidable yet Unresolved Interplay between Endometriosis and Obesity. ScientificWorldJournal. 2021;6653677. https://doi.org/10.1155/2021/6653677Test.; Rathore N., Kriplani A., Yadav R.K., Jaiswal U., Netam R. Distinct peritoneal fluid ghrelin and leptin in infertile women with endometriosis and their correlation with interleukin-6 and vascular endothelial growth factor. Gynecol Endocrinol. 2014;30(9):671–675. https://doi.org/10.3109/09513590.2014.920318Test.; Hanson F.K., Kishan R., Macleay K., Riese, C.S. Investigating the Association Between Metabolic Syndrome and Adenomyosis. Obstet Gynecol. 2020;135:25S. https://doi.org/10.1097/01.aog.0000663176.96985.e4Test.; Heavy menstrual bleeding: assessment and management. London: NICE; 2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK493300Test/.; Singh S., Best C., Dunn S., Leyland N., Wolfman W.L. Clinical Practice Gynecology Committee. Abnormal uterine bleeding in premenopausal women. J Obstet Gynaecol Can. 2013;35(5):473–479. https://doi.org/10.1016/j.jogc.2018.03.007Test.; Munro M.G., Critchley H.O.D., Fraser I.S. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408. https://doi.org/10.1002/ijgo.12666Test.; Reavey J.J., Walker C., Murray A.A., Brito-Mutunayagam S., Sweeney S., Nicol M., Cambursano A. et al. Obesity is associated with heavy menstruation that may be due to delayed endometrial repair. J Endocrinol. 2021;249(2):71–82. https://doi.org/10.1530/JOE-20-0446Test.; Shaw E., Farris M., McNeil J., Friedenreich C. Obesity and Endometrial Cancer. Recent Results Cancer Res. 2016;208:107–136. https://doi.org/10.1007/978-3-319-42542-9_7Test.; Wise M.R., Jordan V., Lagas A., Showell M., Wong N., Lensen S., Farquhar C.M. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. Am J Obstet Gynecol. 2016;214(6):689.e1–689.e17. https://doi.org/10.1016/j.ajog.2016.01.175Test.; Yang X., Wang J. The Role of Metabolic Syndrome in Endometrial Cancer: A Review. Front Oncol. 2019;9:744. https://doi.org/10.3389/fonc.2019.00744Test.; Chu Y., Wang Y., Peng W., Xu L., Liu M., Li J. et al. STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis. Biochem Biophys Res Commun. 2018;500(3):626–631. https://doi.org/10.1016/j.bbrc.2018.04.121Test.; Zahid H., Subbaramaiah K., Iyengar N.M., Zhou X.K., Chen I.C., Bhardwaj P. et al. Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link. Int J Obes (Lond). 2018;42(4):711–720. https://doi.org/10.1038/ijo.2017.273Test.; Song N.Y., Lee Y.H., Na H.K., Baek J.H., Surh Y.J. Leptin induces SIRT1 expression through activation of NF-E2-related factor 2: Implications for obesity-associated colon carcinogenesis. Biochem Pharmacol. 2018;153:282–291. https://doi.org/10.1016/j.bcp.2018.02.001Test.; Wang P.P., He X.Y., Wang R., Wang Z., Wang Y.G. High leptin level is an independent risk factor of endometrial cancer: a meta-analysis. Cell Physiol Biochem. 2014;34(5):1477–1484. https://doi.org/10.1159/000366352Test.; Giannella L., Mfuta K., Setti T., Cerami L.B., Bergamini E., Boselli F. A risk-scoring model for the prediction of endometrial cancer among symptomatic postmenopausal women with endometrial thickness > 4 mm. Biomed Res Int. 2014; 130569. https://doi.org/10.1155/2014/130569Test.; Van Hanegem N., Breijer M.C., Khan K.S., Clark T.J., Burger M.P., Mol B.W., Timmermans A. Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach. Maturitas. 2011;68(2):155–164. https://doi.org/10.1016/j.maturitas.2010.11.010Test.; Kim M.J., Kim J.J., Kim S.M. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women. Obstet Gynecol Sci. 2016;59(3):192–200. https://doi.org/10.5468/ogs.2016.59.3.192Test.; Van den Bosch T., Ameye L., Van Schoubroeck D., Bourne T., Timmerman D. Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Facts Views Vis Obgyn. 2015;7(1):17–24. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402439Test.; Giannella L., Cerami L.B., Setti T., Bergamini E., Boselli F. Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding. Biomed Res Int. 2019;8598152. https://doi.org/10.1155/2019/8598152Test.; Wise M.R., Gill P., Lensen S., Thompson J.M., Farquhar C.M. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am J Obstet Gynecol. 2016;215(5):598.e1–598.e8. https://doi.org/10.1016/j.ajog.2016.06.006Test.; Guraslan H., Dogan K., Kaya C., Senturk M.B., Guraslan B., Helvacioglu C. et al. Could body mass index be an indicator for endometrial biopsy in premenopausal women with heavy menstrual bleeding? Arch Gynecol Obstet. 2016;294(2):395–402. https://doi.org/10.1007/s00404-016-4043-8Test.; Gao Y., Dai X., Lee A.C., Wise M.R., Shen F., Chen Q. Body Mass Index is Negatively Associated with Endometrial Cancer Stage, Regardless of Subtype and Menopausal Status. J Cancer. 2018;9(24):4756–4761. https://doi.org/10.7150/jca.21137Test.; Akalyaa K., Shakuntala P.N., Renuka P. Correlation of body mass index and abnormal uterine bleeding in premenopausal women. Int J Reprod Contracept Obstet Gynecol. 2020;9(11):4640–4647. https://doi.org/10.18203/2320-1770.ijrcog20204826Test.; Singh S., Best C., Dunn S., Leyland N., Wolfman W.L. Abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2013;35(5):473–475. https://doi.org/10.1016/S1701-2163Test(15)30939-7.; Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004;19:176–182. https://doi.org/10.1152/physiol.00001.2004Test.; Maybin J.A., Murray A.A., Saunders P., Hirani N., Carmeliet P., Critchley H. Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation. Nat Commun. 2018;9(1):295. https://doi.org/10.1038/s41467-017-02375-6Test.; Chen X., Liu J., He B., Li Y., Liu S., Wu B. Vascular endothelial growth factor (VEGF) regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial breakdown, not repair, in a mouse menstrual-like model. Hum Reprod. 2015;30(9):2160–2170. https://doi.org/10.1093/humrep/dev156Test.; Goossens G.H., Blaak E.E. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol (Lausanne). 2015;6:55. https://doi.org/10.3389/fendo.2015.00055Test.; Nouri M., Tavakkolian A., Mousavi S.R. Association of dysfunctional uterine bleeding with high body mass index and obesity as a main predisposing factor. Diabetes Metab Syndr. 2014;8(1):1–2. https://doi.org/10.1016/j.dsx.2013.10.013Test.; Cousins F.L., Murray A.A., Scanlon J.P., Saunders P.T. Hypoxyprobe™ reveals dynamic spatial and temporal changes in hypoxia in a mouse model of endometrial breakdown and repair. BMC Res Notes. 2016;9:30. https://doi.org/10.1186/s13104-016-1842-8Test.; Jafari-Gharabaghlou D., Vaghari-Tabari M., Oghbaei H., Lotz L., Zarezadeh R., Rastgar Rezaei Y. et al. Role of adipokines in embryo implantation.; https://www.med-sovet.pro/jour/article/view/6788Test

الإتاحة: https://doi.org/10.21518/2079-701X-2022-16-5-32-39Test
https://doi.org/10.1038/ijo.2008.102Test
https://doi.org/10.1016/S0140-6736Test(11)60814-3
https://doi.org/10.1007/s00134-019-05594-1Test
https://doi.org/10.1016/j.fertnstert.2017.01.017Test
https://doi.org/10.1159/000438957Test
https://doi.org/10.1159/000438881Test
https://doi.org/10.33029/1816-2134-2020-16-3-64-72Test
https://doi.org/10.1016/j.fertnstert.2012.01.126Test
https://doi.org/10.1093/molehr/gav025Test

المؤلفون: Енькова, Е. В., Киселева, Е. В., Хоперская, О. В., Хатунцев, А. В., Тюрина, И. Д.

مصطلحات موضوعية: медицина, клиническая медицина, гинекология, маточное кровотечение, аномальное маточное кровотечение, тяжелое менструальное кровотечение, полип эндометрия, аденомиоз, миома матки, рак эндометрия, гиперплазия эндометрия

العلاقة: Аномальные маточные кровотечения: этиология и патогенез : описательный обзор / Е. В. Енькова [и др.] // Научные результаты биомедицинских исследований. - 2022. - Т.8, №3.- С. 365-381. - Doi:10.18413/2658-6533-2022-8-3-0-8. - Библиогр.: с. 375-381.; http://dspace.bsu.edu.ru/handle/123456789/48345Test

الإتاحة: https://doi.org/10.18413/2658-6533-2022-8-3-0-8Test
http://dspace.bsu.edu.ru/handle/123456789/48345Test

المؤلفون: Федосюк, К.В.

المصدر: Репродуктивне здоров'я жінки; № 9-10 (2021); 39-41 ; Reproductive health of woman; № 9-10 (2021); 39-41 ; Reproductive health of woman; No. 9-10 (2021); 39-41 ; 2708-8731 ; 2708-8723

مصطلحات موضوعية: аномальное маточное кровотечение, репродуктивный возраст, хронический стресс, гормоны, abnormal uterine bleeding, reproductive age, chronic stress, hormones, аномальна маткова кровотеча, репродуктивний вік, хронічний стрес, гормони

وصف الملف: application/pdf

العلاقة: http://repro-health.com.ua/article/view/252587/249920Test; http://repro-health.com.ua/article/view/252587Test

الإتاحة: https://doi.org/10.30841/2708-8731.9-10.2021.252587Test
http://repro-health.com.ua/article/view/252587Test

المؤلفون: Федосюк, К.В.

المصدر: Репродуктивне здоров'я жінки; № 7-8 (2021); 63-65 ; Reproductive health of woman; № 7-8 (2021); 63-65 ; Reproductive health of woman; No. 7-8 (2021); 63-65 ; 2708-8731 ; 2708-8723

مصطلحات موضوعية: abnormal uterine bleeding, reproductive age, stress, anxiety, аномальное маточное кровотечение, репродуктивный возраст, стресс, тревожность, аномальна маткова кровотеча, репродуктивний вік, стрес, тривожність

وصف الملف: application/pdf

العلاقة: http://repro-health.com.ua/article/view/250836/248664Test; http://repro-health.com.ua/article/view/250836Test

الإتاحة: https://doi.org/10.30841/2708-8731.7-8.2021.250836Test
http://repro-health.com.ua/article/view/250836Test

المؤلفون: Бирчак, І., Ясніковська, С., Гошовська, А.

المصدر: Bukovinian Medical Herald; Vol. 25 No. 2(98) (2021); 9-12 ; Буковинский медицинский вестник; Том 25 № 2(98) (2021); 9-12 ; Буковинський медичний вісник; Том 25 № 2(98) (2021); 9-12 ; 2413-0737 ; 1684-7903

مصطلحات موضوعية: abnormal uterine bleeding, submucosal uterine fibroids, аномальное маточное кровотечение, субмукозная миома матки, аномальна маткова кровотеча, субмукозна міома матки

وصف الملف: application/pdf

العلاقة: http://e-bmv.bsmu.edu.ua/article/view/239623/238076Test; http://e-bmv.bsmu.edu.ua/article/view/239623Test

الإتاحة: https://doi.org/10.24061/2413-0737.XXV.2.98.2021.2Test
http://e-bmv.bsmu.edu.ua/article/view/239623Test

المؤلفون: Byrchak, I. V., Kuritsyna, S. A.

المصدر: Actual Problems of Pediatry, Obstetrics and Gynecology; No. 1 (2016) ; Актуальные вопросы педиатрии, акушерства и гинекологии; № 1 (2016) ; Актуальні питання педіатрії, акушерства та гінекології; № 1 (2016) ; 2415-301X ; 2411-4944 ; 10.11603/24116-4944.2016.1

مصطلحات موضوعية: abnormal uterine bleeding, haemostasis system, аномальное маточное кровотечение, агрегатное состояние крови, аномальна маткова кровотеча, агрегатний стан крові

وصف الملف: application/pdf

العلاقة: https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/5981/5478Test; https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/5981Test; https://repository.tdmu.edu.ua//handle/123456789/14505Test

الإتاحة: https://doi.org/10.11603/24116-4944.2016.1.5981Test
https://doi.org/10.11603/24116-4944.2016.1Test
https://repository.tdmu.edu.ua//handle/123456789/14505Test
https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/5981Test

المؤلفون: E. V. Sibirskaya, L. V. Adamyan, S. P. Yatsyk, I. F. Tin, S. G. Geras'kina

المصدر: Вопросы современной педиатрии, Vol 13, Iss 4, Pp 136-139 (2014)

مصطلحات موضوعية: аномальное маточное кровотечение пубертатного периода, гормональный статус, репродуктивное здоровье женщин, Pediatrics, RJ1-570

وصف الملف: electronic resource

العلاقة: https://vsp.spr-journal.ru/jour/article/view/181Test; https://doaj.org/toc/1682-5527Test; https://doaj.org/toc/1682-5535Test

الوصول الحر: https://doaj.org/article/b54cf0825da94e7b82c4dfdac50282e9Test

المصدر: Репродуктивне здоров'я жінки; № 9-10 (2021); 39-41
Reproductive health of woman; № 9-10 (2021); 39-41
Reproductive health of woman; No. 9-10 (2021); 39-41

مصطلحات موضوعية: endocrine system, аномальна маткова кровотеча, хронічний стрес, аномальное маточное кровотечение, hormones, хронический стресс, гормони, репродуктивный возраст, гормоны, репродуктивний вік, reproductive age, abnormal uterine bleeding, hormones, hormone substitutes, and hormone antagonists, chronic stress

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=scientific_p::fdc648ec62e40a9f29e621ae480842d7Test
http://repro-health.com.ua/article/view/252587Test